SAN DIEGO, November 12, 2019 – ProSciento, Inc., a clinical research organization (CRO) exclusively focused on diabetes, NASH, obesity and related metabolic diseases, will present clinical research data at the 19th Annual Diabetes Technology Meeting, November 14-16 in North Bethesda, Maryland.
Poster presentations by ProSciento:
- Glucose Clamp Quality Parameters Among Study Populations
Authors: Alejandra Macias Pulido, MD; Linda Morrow, MD; Gabriela Campos-Cortes, MD; Julie Willard, MD; Moises Hernandez, MD; Marcus Hompesch, MD
- Effect of Dawn Phenomenon on Glucose Infusion Rate During Glucose Clamp Studies in Subjects with Type 1 Diabetes
Authors: Bridgette Boggess Franey, MD; Alejandra Macias Pulido, MD; Linda Morrow, MD; Marcus Hompesch, MD
To inquire about a meeting with a member of ProSciento’s scientific team during the Diabetes Technology Meeting or at a future date, please click here or email us at bd@prosciento.com.
About ProSciento, Inc.
ProSciento is a highly specialized clinical research organization (CRO)
exclusively focused on NASH, diabetes, obesity and related metabolic diseases.
ProSciento works with biopharma companies worldwide to support their outsourced
clinical research needs with comprehensive and customized services for
multinational, early development clinical trial programs. Founded in 2003,
ProSciento has conducted more than 280 clinical projects for diabetes, NASH and
obesity and supported the development of many approved metabolic drugs and
devices on the market globally. For more information, please visit www.prosciento.com.
For business development inquiries, please contact:
bd@prosciento.com
For media inquiries, please contact:
Abby Devine
Senior Director, Corporate Communications, ProSciento, Inc.
abby.devine@prosciento.com
For clinical trial enrollment inquires:
Tel: +1 (866) 308-7427
volunteer@prosciento.com
